Company Monitoring Page for Roche

latest headlines for company on cafepharma

Roche’s Vismodegib Meets Main Goal of Advanced Skin-Cancer Study
Bloomberg
Sat, 09/24/11 - 12:43 pm
Tags:
vismodegib, Roche, basal cell carcinoma, skin cancer
Roche, Mylan Settle Patent Case Over Drug Xeloda
Bloomberg
Thu, 09/22/11 - 08:30 am
Tags:
Mylan, Roche, patents, Xeloda, cancer
Regeneron Soars on Eye-Drug Rival Setback
TheStreet.com
Wed, 09/21/11 - 11:24 pm
Tags:
Regeneron, Roche, Avastin, wet-AMD, age-related macular degeneration
What's Bad For Bisphosphonates Is Good For Emisphere
Seeking Alpha
Tue, 09/13/11 - 10:18 am
Tags:
Emisphere, bisphosphonates, Amgen, Merck, Novartis, Roche, Sanofi
Roche Seeks FDA Approval for Skin Cancer Drug
Bloomberg
Mon, 09/12/11 - 09:58 am
Tags:
FDA, Roche, skin cancer, vismodegib
Bone Drugs Need Label Changes on Use Duration, Panel Says
Bloomberg
Sat, 09/10/11 - 10:40 am
Tags:
Warner Chilcott, Roche, Merck, Novartis, osteoporosis, bone growth, Actonel, Boniva, Reclast, Fosamax
GSK stops Tykerb-only arm in cancer trial
Fierce Pharma
Fri, 09/9/11 - 12:02 pm
Tags:
GSK, Tykerb, Roche, Herceptin, breast cancer
Off-Label Avastin Use, Medicare And Saving Money
Pharmalot
Wed, 09/7/11 - 09:54 am
Tags:
Medicare, off-label, Avastin, Roche, Genentech, age-related macular degeneration
Roche Signs First Alzheimer's Deal Of 2011 As Crucial Progress Awaited
Seeking Alpha
Wed, 09/7/11 - 09:34 am
Tags:
Roche, Alzheimer's disease, Ranbaxy, Elan, JNJ, Eli Lilly, Pfizer
Roche to maintain lead in targeted drugs
Yahoo/Reuters
Wed, 08/31/11 - 12:55 pm
Tags:
Roche, targeted therapeutics, Novartis, Pfizer
Off-Label Avastin Injections Linked To Blindness
Pharmalot
Wed, 08/31/11 - 09:31 am
Tags:
off-label, blindness, Avastin, Genentech, Roche
Power outages, floods close offices of drugmakers
Yahoo/AP
Mon, 08/29/11 - 05:37 pm
Tags:
weather, Hurricane Irene, JNJ, GSK, Bayer, Teva Pharmaceuticals, Cephalon, Roche
Bone drug tied to lower colon cancer risk
Yahoo/Reuters
Tue, 08/23/11 - 08:26 am
Tags:
colon cancer, biophosphonates, Merck, Fosamax, Roche, Boniva, Novartis, Reclast, Actonel, Warner Chilcott
Roche CEO Schwan spotlights Roche's top three blockbuster hopefuls
Fierce Biotech
Mon, 08/22/11 - 01:16 pm
Tags:
Roche, Severin Schwan, Metmab, lung cancer, lebrikizumab, Pertuzumab, asthma, breast cancer
Roche Rises After Good-Cholesterol Drug Shows Promise in Study
Bloomberg
Mon, 08/22/11 - 10:33 am
Tags:
Roche, dalcetrapib
Roche Seeks Win on Heart Pill Where Pfizer Failed
Bloomberg
Fri, 08/19/11 - 09:07 am
Tags:
Roche, Pfizer, dalcetrapib, heart disease
Roche, Daiichi Sankyo Win U.S. Approval on Drug to Treat Advanced Melanoma
Bloomberg
Wed, 08/17/11 - 12:03 pm
Tags:
Zelboraf, Roche, melanoma, FDA, Daiichi Sankyo
Regeneron Says FDA Delays Eylea Drug for Blindness
Bloomberg
Wed, 08/17/11 - 08:27 am
Tags:
Regeneron, FDA, blindness, Eylea, Lucentis, Roche
Roche licenses vemurafenib to Chugai
Pharmaceutical Business Review
Mon, 08/15/11 - 12:25 pm
Tags:
Roche, vemurafenib, Chugai, melanoma, BRAF inhibitor
Roche/Array: 2 Shots Are Better Than 1
Seeking Alpha
Fri, 08/12/11 - 12:45 pm
Tags:
Roche, Array Biopharma, ChK-1 inhibitors, cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.